HALO logo
halo search icon
BioCardia, Inc.
BioCardia, Inc.
BCDA · NAS

BioCardia, Inc.

US$0.92

Price Arrow-0.0309 (-3.25%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BearishHALO AllNear SupportRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BioCardia, Inc. Overview

BCDA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BCDA

icon

Telephone

1.650.226.0120

icon

Address

320 Soquel Way, Sunnyvale, CA 94085

Description

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and AVANCE Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

BCDA Price Chart

Key Stats

Market Cap

US$10.82M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.84 - 2.45

Trade Value (12mth)

US$103,566.00

1 week

-5.85%

1 month

-20.76%

YTD

-25.13%

1 year

-49.42%

All time high

10044.00

Key Fundamentals

EPS 3 yr Growth

-87.80%

EBITDA Margin

0.00%

Operating Cashflow

-$7m

Free Cash Flow Return

-623.80%

ROIC

-690.30%

Interest Coverage

0.00

Quick Ratio

1.10

Other Data

Shares Outstanding (Fully Diluted)

11m

HALO Sector

Healthcare

Next Company Report Date

30-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BCDA Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
08 May 26
08 May 26
28 April 26

BCDA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-8.19-2.9-1.23locklocklock
EPS (Fully Diluted)
$locklocklocklock-8.19-2.9-1.23locklocklock
Growth
%locklocklocklock18.764.757.4locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of BioCardia, Inc. (BCDA:NAS)?
Halo FAQ
The current share price of BioCardia, Inc. (BCDA:NAS) is USD$0.92.
What is the 52-week high share price for BioCardia, Inc. (BCDA:NAS)?
Halo FAQ
The 52-week high share price for BioCardia, Inc. (BCDA:NAS) is USD$2.45.
What is the 52-week low share price for BioCardia, Inc. (BCDA:NAS)?
Halo FAQ
The 52-week low share price for BioCardia, Inc. (BCDA:NAS) is USD$0.84.
What is the dividend yield for BioCardia, Inc. (BCDA:NAS)?
Halo FAQ
BioCardia, Inc. (BCDA:NAS) does not pay a dividend.
What was BioCardia, Inc. (BCDA:NAS) last dividend payment?
Halo FAQ
BioCardia, Inc. (BCDA:NAS) does not pay a dividend.
What is the franking level for BioCardia, Inc. (BCDA:NAS)?
Halo FAQ
BioCardia, Inc. (BCDA:NAS) has a franking level of 0.00%.
In which sector is BioCardia, Inc. (BCDA:NAS) classified?
Halo FAQ
BioCardia, Inc. (BCDA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.